Valve involvement in infective endocarditis among intravenous drug users: a systematic review and meta-analysis
Authors:
- Minh H. N. LeMinh H. N. Le
- Hung H. PhanHPHung H. Phan
- Vien T. TruongVTVien T. Truong
- Minh P. TangMTMinh P. Tang
- Phat K. NguyenPNPhat K. Nguyen
- An Thuy VoAVAn Thuy Vo
- Loc T. VuLVLoc T. Vu
- Duy ChungDCDuy Chung
- Chi N. DuongCDChi N. Duong
- Quoc BuiQBQuoc Bui
- Han H. HuynhHHHan H. Huynh
- Trang D. T. LeTLTrang D. T. Le
Open Access
- 12 May 2026
- journal article
- review article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Abstract
Background: Intravenous drug use (IVDU) is a major risk factor for infective endocarditis (IE), with right-sided infective endocarditis (RSIE) most frequently observed. However, precise estimates of valve involvement and the relative risk (RR) of RSIE within the IVDU population remain unclear. This systematic review and meta-analysis aimed to quantify the prevalence of RSIE, left-sided IE (LSIE), both-sided IE, and valve-specific involvement in IVDUs while assessing the relative risk of right-sided versus left-sided IE within the IVDU population. Methods: A systematic search was conducted in PubMed, Embase, and Web of Science to identify studies reporting IE in IVDUs. Inclusion criteria followed the PICO framework, ensuring clear definitions of IVDU status and valve involvement. A random-effects model was used to calculate pooled prevalence estimates and RR ratios with 95% confidence intervals (CIs). Heterogeneity was assessed using the I² statistic, and sensitivity analyses were performed. Results: A total of 14 studies involving 1,783 patients met the inclusion criteria. The pooled prevalence of right-sided infective endocarditis (RSIE) was 59% (95% CI: 54%–65%), left-sided infective endocarditis (LSIE) was 39% (95% CI: 33%–46%), and both-sided infective endocarditis was 8% (95% CI: 6%–12%). Among individual valves, the tricuspid valve was most commonly affected (59% (95% CI: 53%–64%)), followed by the mitral valve (21% (95% CI: 18%–26%)) and the aortic valve (16% (95% CI: 12%–20%)). Pulmonic valve involvement was rare (1% (95% CI: 0%–3%)). Overall, individuals who inject drugs (IVDUs) had a 1.49-fold increased risk of developing right-sided IE compared to left-sided IE (RR = 1.49 (95% CI: 1.15–1.95), p = 0.008). Conclusion: This SRMA confirms the predominance of right-sided IE, particularly tricuspid valve involvement, in IVDUs, with a significantly higher risk compared to left-sided IE. The findings underscore the need for targeted screening, early intervention, and IVDU-specific management strategies in IE care. Future research should focus on regional variations, microbiological patterns, and long-term outcomes in this high-risk population. Clinical trial number: Not applicable.Keywords
This publication has 37 references indexed in Scilit:
- Role of echocardiography in the diagnosis and clinical management of infective endocarditisIndian Journal of Thoracic and Cardiovascular Surgery, 2024
- Impact of Opioid Epidemic on Infective Endocarditis Outcomes in the United States: From the National Readmission DatabaseThe American Journal of Cardiology, 2022
- Peripherally Inserted Central Catheter Line Misuse Among People Who Inject Drugs While on Therapy for Infective EndocarditisThe American Journal of Medicine, 2022
- Recent Trends in Infective Endocarditis Among Patients with and Without Injection Drug Use: An Eight-Year Single Center StudyThe American Journal of the Medical Sciences, 2021
- Left-sided infective endocarditis in persons who inject drugsInfection, 2020
- Clinical Characteristics and Factors Associated With Mortality in First-Episode Infective Endocarditis Among Persons Who Inject DrugsJAMA Network Open, 2018
- Meta-analysis in clinical trials revisitedContemporary Clinical Trials, 2015
- Infective Endocarditis in Intravenous Drug Users from Italy: the Increasing Importance in HIV-infected PatientsInfection, 2007
- Periannular Complications in Infective Endocarditis Involving Prosthetic Aortic ValvesThe American Journal of Cardiology, 2006
- A graphical method for exploring heterogeneity in meta‐analyses: application to a meta‐analysis of 65 trialsStatistics in Medicine, 2002